Euclidean Capital as of Dec. 31, 2023
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 13 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 49.1 | $436M | 917k | 475.31 | |
| Spdr Gold Tr Gold Shs (GLD) | 29.9 | $266M | 1.4M | 191.17 | |
| Ishares Tr Msci India Etf (INDA) | 13.3 | $118M | 2.4M | 48.81 | |
| Rapt Therapeutics (RAPT) | 1.8 | $16M | 658k | 24.85 | |
| Alector (ALEC) | 1.2 | $10M | 1.3M | 7.98 | |
| Foghorn Therapeutics (FHTX) | 1.1 | $10M | 1.6M | 6.45 | |
| 23andme Holding Class A Com (ME) | 1.1 | $9.4M | 10M | 0.91 | |
| Oric Pharmaceuticals (ORIC) | 1.0 | $9.1M | 989k | 9.20 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $8.1M | 2.6M | 3.10 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $3.3M | 1.0M | 3.24 | |
| Ngm Biopharmaceuticals | 0.1 | $852k | 992k | 0.86 | |
| Surrozen Com New (SRZN) | 0.1 | $824k | 88k | 9.40 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.3k | 171k | 0.02 |
